利用远程医疗工具在初级保健中早期发现皮肤肿瘤 (MEL)
在初级保健中使用远程医疗工具早期检测皮肤肿瘤
The project is a national, prospective, multicenter, single-arm interventional pilot of screening skin tumors in the Czech Republic.
The primary aim of the project is to methodically prepare, implement and evaluate a pilot project that will verify the suitability of the proposed procedure of early detection of skin tumors by using a telemedicine tools and setting up and testing new methods and implementation into the system of social health care.
研究概览
详细说明
The project is a national, prospective, multicenter, single-arm interventional pilot project for skin tumors screening involving 18 general practitioners and 6 dermatology centers in the Czech Republic.
The main objective of the project is the early detection of skin tumors by general practitioners, increasing the efficiency of healthcare, and methodically preparing, implementing, and evaluating the pilot project. The project aims to verify the suitability of the proposed early detection procedure for skin tumors, as well as to establish and test new methods and integrate them into the healthcare system.
As part of the project, the procedure will be tested on a sample of approximately 1,440 individuals, which may help validate the use of telemedicine tools in healthcare. A methodology for the use of telemedicine tools will be developed, along with a framework for collaboration between general practitioners and affiliated dermatologists. Systemic changes will be proposed to enhance the efficiency of the screening process.
The project is supported by the European Social Fund (Operational Programme Employment Plus) and the state budget of the Czech Republic. It is registered with the Ministry of Labour and Social Affairs of the Czech Republic under ID: CZ.03.02.02/00/22_005/0002008.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Dagmar Obšilová, Msc
- 电话号码:+420606429382
- 邮箱:dagmar.obsilova@uzis.cz
研究联系人备份
- 姓名:Lucie Mandelova, Ph.D.
- 电话号码:+420 770190 828
- 邮箱:lucie.mandelova@uzis.cz
学习地点
-
-
-
Brno、捷克语
- 尚未招聘
- St. Anne's University Hospital Brno
-
接触:
- Hana Jedličková, prof.
- 邮箱:hjedlic@medmuni.cz
-
Olomouc、捷克语
- 招聘中
- Olomouc University Hospital
-
接触:
- Zdeněk Drlík, MD
- 邮箱:zdenek.drlik@fnol.cz
-
Pilsen、捷克语
- 尚未招聘
- University Hospital Pilsen
-
接触:
- Jan Říčař, MD, Ph.D.
- 邮箱:ricarj@fnplzen.cz
-
Prague、捷克语
- 招聘中
- Bulovka University Hospital
-
接触:
- Filip Rob, Assoc. Prof.
- 邮箱:filip.rob@bulovka.cz
-
Prague、捷克语
- 尚未招聘
- University hospital Kralovske Vinohrady
-
接触:
- Petr Arenberger, prof.
- 邮箱:petr.arenberger@lf3.cuni.cz
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- at least 1 suspected lession
- phototype I or phototype II
Exclusion Criteria:
- skin lession examination by dermatologist in last 12 months
- unsigned consent to participate in the project and consent to the processing of personal data
学习计划
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Adults with suspected skin lession
Pilot screening will be conducted in general practitioners' offices, where physicians will be trained to examine skin lesions using magnifying devices (dermatoscopes) and advanced telemedicine software, enabling faster diagnostics of suspicious findings. Patients with high-risk lesions will be referred to specialized dermatology centers. |
The diagnostic management of enrolled patients will be guided by standardized procedures carried out in general practitioners' offices. Physicians will be trained to identify suspicious skin lesions, capture high-resolution images using dermatoscopes, and transfer the data into advanced telemedicine software. The platform, supported by AI-driven algorithms, enables precise risk stratification of lesions and facilitates remote consultation with collaborating dermatologists. Patients with high-risk lesions will be referred to specialized dermatology centers for further examination and intervention. In cases where excision of a lesion is performed, histopathological assessment will be conducted, and results will be systematically recorded within the dedicated telemedicine platform, ensuring secure and efficient information exchange between dermatologists and general practitioners. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Potential malignancies
大体时间:From enrollment to the end of examination - baseline.
|
Proportion of individuals with a potential presence of malignancy (detected through the telemedicine tool). |
From enrollment to the end of examination - baseline.
|
|
Confirmed malignancies
大体时间:From enrollment to the end of diagnosis at 3 months.
|
Proportion of individuals with confirmed potential malignancy by a dermatologist. |
From enrollment to the end of diagnosis at 3 months.
|
|
Confirmed malignancies by histology
大体时间:From enrollment to the end of diagnosis at 6 months.
|
Proportion of individuals in whom the diagnosis of malignancy was confirmed histologically. |
From enrollment to the end of diagnosis at 6 months.
|
合作者和调查者
调查人员
- 研究主任:Petr Arenberger, prof.、Hospital university Kralovske Vinohrady
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.